Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Lambertini

Showing results (131-140 of 375) with videos related to

Pageof 38
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 24, 2020
Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studiesKamal S Saini, Marco Tagliamento, Matteo Lambertini, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2021
Cancer survivorship: Reproductive health outcomes should be included in standard toxicity assessmentsRichard A Anderson, Florian Clatot, Isabelle Demeestere, et al.
Breast (Edinburgh, Scotland)|February 24, 2018
Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancerChristian Maurer, Arlindo R Ferreira, Samuel Martel, et al.
Maturitas|November 5, 2024
Menopausal symptoms in breast cancer survivors on adjuvant endocrine therapy compared with those of menopausal womenGiorgia Asinaro, Claudia Massarotti, Anjeza Xholli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2021
Association between pertuzumab-associated diarrhoea and rash and survival outcomes in patients with HER2-positive metastatic breast cancer: Exploratory analysis from the CLEOPATRA trialArlindo R Ferreira, Sofia Ferreira, Matteo Lambertini, et al.
ESMO Open|October 29, 2020
Gender-specific aspects related to type of fertility preservation strategies and access to fertility careMarta Perachino, Claudia Massarotti, Maria Grazia Razeti, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2016
Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical OncologyMatteo Lambertini, Michela Cinquini, Ivan Moschetti, et al.
NPJ Breast Cancer|October 16, 2020
Clinical utility of genomic signatures in young breast cancer patients: a systematic reviewCynthia Villarreal-Garza, Ana S Ferrigno, Cynthia De la Garza-Ramos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2015
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trialMatteo Lambertini, Paolo Bruzzi, Francesca Poggio, et al.
Cancer Treatment Reviews|July 28, 2017
Fertility and pregnancy issues in BRCA-mutated breast cancer patientsMatteo Lambertini, Oranite Goldrat, Angela Toss, et al.
Pageof 38

Showing results (131-140 of 375) with videos related to

Sort By:
Pageof 38
European Journal of Cancer (Oxford, England : 1990)|September 24, 2020
Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studiesKamal S Saini, Marco Tagliamento, Matteo Lambertini, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2021
Cancer survivorship: Reproductive health outcomes should be included in standard toxicity assessmentsRichard A Anderson, Florian Clatot, Isabelle Demeestere, et al.
Breast (Edinburgh, Scotland)|February 24, 2018
Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancerChristian Maurer, Arlindo R Ferreira, Samuel Martel, et al.
Maturitas|November 5, 2024
Menopausal symptoms in breast cancer survivors on adjuvant endocrine therapy compared with those of menopausal womenGiorgia Asinaro, Claudia Massarotti, Anjeza Xholli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2021
Association between pertuzumab-associated diarrhoea and rash and survival outcomes in patients with HER2-positive metastatic breast cancer: Exploratory analysis from the CLEOPATRA trialArlindo R Ferreira, Sofia Ferreira, Matteo Lambertini, et al.
ESMO Open|October 29, 2020
Gender-specific aspects related to type of fertility preservation strategies and access to fertility careMarta Perachino, Claudia Massarotti, Maria Grazia Razeti, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2016
Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical OncologyMatteo Lambertini, Michela Cinquini, Ivan Moschetti, et al.
NPJ Breast Cancer|October 16, 2020
Clinical utility of genomic signatures in young breast cancer patients: a systematic reviewCynthia Villarreal-Garza, Ana S Ferrigno, Cynthia De la Garza-Ramos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2015
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trialMatteo Lambertini, Paolo Bruzzi, Francesca Poggio, et al.
Cancer Treatment Reviews|July 28, 2017
Fertility and pregnancy issues in BRCA-mutated breast cancer patientsMatteo Lambertini, Oranite Goldrat, Angela Toss, et al.
Pageof 38